Immunogenicity of a single-dose compared with a two-dose primary series followed by a booster dose of ten-valent or 13-valent pneumococcal conjugate vaccine in South African children: an open-label, randomised, non-inferiority trial

BACKGROUND: Routine childhood immunisation with pneumococcal conjugate vaccine (PCV) has changed the epidemiology of pneumococcal disease across age groups, providing an opportunity to reconsider PCV dosing schedules. We aimed to evaluate the post-booster dose immunogenicity of ten-valent (PCV10) an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet Infect Dis
Main Authors: Madhi, Shabir A, Mutsaerts, Eleonora AML, Izu, Alane, Boyce, Welekazi, Bhikha, Sutika, Ikulinda, Benit T, Jose, Lisa, Koen, Anthonet, Nana, Amit J, Moultrie, Andrew, Roalfe, Lucy, Hunt, Adam, Goldblatt, David, Cutland, Clare L, Dorfman, Jeffrey R
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier Science ;, The Lancet Pub. Group 2020
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7689288/
https://ncbi.nlm.nih.gov/pubmed/32857992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(20)30289-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados